Long-term clinical experience with the Omnicarbon prosthetic valve

Annals of Thoracic Surgery

Volumn 68, Issue 3, 1999, Pages 881-886

  Torregrosa, Salvador ^a   Gómez Plana, Jesús ^a   Valera, Francisco J ^a   Caffarena, José ^a   Maroñas, José M ^a   García Sánchez, Francisco ^a   Peris, José ^a   Frías, Ramón ^a   Caffarena, José M ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AORTA VALVE REPLACEMENT; CHILD; CONFERENCE PAPER; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANEMIA, HEMOLYTIC; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROSTHESIS FAILURE; REOPERATION; SURVIVAL RATE; THROMBOEMBOLISM;

EID: 0345148847     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00557-3     Document Type: Conference Paper

References (23)

1. Edmunds L.H. Jr, Clark R.E., Cohn L.H., Grunkemeier G.L., Miller D.C., Weisel R.D. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg. 62:1996;932-935.
2. Watanabe N., Abe T., Yamada O., et al. Comparative analysis of Omniscience and Omnicarbon prosthesis after aortic valve replacement. Jpn J Artif Organs. 18:1989;773-776.
3. Abe T., Kamata K., Kuwaki K., Komatsu K., Komatsu S. Ten years' experience of aortic valve replacement with the Omnicarbon valve prosthesis. Ann Thorac Surg. 61:1996;1182-1187.
4. Misawa Y., Hasegawa T., Kato M. Clinical experience with the Omnicarbon prosthetic heart valve. J Thorac Cardiovasc Surg. 105:1993;168-172.
5. Peter M., Weiss P., Jenzer H.R., et al. The Omnicarbon tilting-disc heart valve prosthesis. J Thorac Cardiovasc Surg. 106:1993;599-608.
6. Thevenet A., Albat B. Long term follow up of 292 patients after valve replacement with the Omnicarbon prosthetic valve. J Heart Valve Dis. 4:1995;634-639.
7. Cannegieter S.C., Rosendaal F.R., Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 89:1994;635-641.
8. Akins C.W. Results with mechanical cardiac valvular prostheses. Ann Thorac Surg. 60:1995;1836-1844.
9. Akins C.W. Long-term results with the Medtronic-Hall valvular prosthesis. Ann Thorac Surg. 61:1996;806-813.
10. Teijeira F.J. Long-term experience with the Omniscience cardiac valve. J Heart Valve Dis. 7:1998;540-547.
11. Kratz J.M., Crawford F.A. Jr, Sade R.M., Crumbley A.J., Stroud M.R. St. Jude prosthesis for aortic and mitral valve replacement a ten-year experience . Ann Thorac Surg. 56:1993;462-468.
12. Khan S., Chaux A., Matloff J., et al. The St. Jude Medical valve. Experience with 1,000 cases. J Thorac Cardiovasc Surg. 108:1994;1010-1020.
13. Milano A., Bortolotti U., Mazzucco A., et al. Heart valve replacement with the Sorin tilting-disc prosthesis. J Thorac Cardiovasc Surg. 103:1992;267-275.
14. Fiore A.C., Barner H.B., Swartz M.T., et al. Mitral valve replacement randomized trial of St. Jude and Medtronic Hall prostheses . Ann Thorac Surg. 66:1998;707-713.
15. Von der Emde J., Köckerling F., Rein J., Hartlein A. Measures of prevention and technical problems during reoperation in cardiac surgery. Thorac Cardiovasc Surg. 34:1986;5-11.
16. Taggart D.P., Spyt T.J., Wheatley D.J., Fisher J. Severe hemolysis with the St. Jude Medical prosthesis. Eur J Cardiothorac Surg. 2:1988;137-142.
17. Jones E.J. St. Jude Medical prosthesis. [Letter] J Thorac Cardiovasc Surg. 81:1981;642.
18. Knott E., Reul H., Knoch M., Steinseifer U., Rau G. In vitro comparison of aortic heart valve prostheses. J Thorac Cardiovasc Surg. 96:1988;952-961.
19. Myers M.L., Lawrie G.M., Crawford E.S., et al. The St. Jude valve prosthesis analysis of the clinical results in 815 implants and the need for systemic anticoagulation . J Am Coll Cardiol. 13:1989;57-62.
20. Damle A., Coles J., Teijeira J., Pelletier C., Callaghan J. A six-year study of the Omniscience valve in four Canadian centers. Ann Thorac Surg. 43:1987;513-521.
21. Czer L.S.C., Chaux A., Matloff J.M., et al. Ten-year experience with the St. Jude Medical valve for primary valve replacement. J Thorac Cardiovasc Surg. 100:1990;44-55.
22. Arom K.V., Nicoloff D.M., Kersten T.E., Lindsay W.G., Northrup W.F. III. St. Jude Medical prosthesis valve-related deaths and complications . Ann Thorac Surg. 43:1987;591-598.
23. Aris A., Igual A., Padró J.M., et al. The Spanish Monostrut Study Group a ten-year experience with 8,599 implants . Ann Thorac Surg. 62:1996;40-47.